Otonomy Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Otonomy program updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Otonomy Program Updates Today - Breaking & Trending Today

Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , Anne Ramsey , Davida Weber , Roberth Uhl , American Society Of Gene Cell Therapy , Drug Administration , Otonomy Inc , Exchange Commission , Development Expenses , Genetic Technologies Corporation Nasdaq , Otonomy Program Updates , Oxford Finance , Tinnitus Functional Index , American English Matrix , Applied Genetic Technologies Corporation , American Society , Cell Therapy , Administrative Expenses , Private Securities Litigation Reform Act , Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , அன்னே ராம்சே , டேவிடா வெபர் , அமெரிக்கன் சமூகம் ஆஃப் கீந் செல் சிகிச்சை , பரிமாற்றம் தரகு , வளர்ச்சி செலவுகள் ,

Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update
Otonomy, Inc.May 11, 2021 GMT
OTO-313 Phase 2 trial in tinnitus initiated with results expected in mid-2022
OTO-413 Phase 1/2 trial expansion in hearing loss expected to start in second quarter of 2021 with results anticipated in mid-2022
OTO-825 IND-enabling activities underway with preclinical proof-of-concept data to be presented at ASGCT meeting; update on program to be provided in mid-2021
Recent financing extends cash runway into second half of 2023
Conference call and webcast today at 4:30 p.m. ET ....

United States , Anne Ramsey , Davida Weber , Roberth Uhl , Co Ltd , American Society Of Gene Cell Therapy , Otonomy Inc , Development Expenses , Exchange Commission , Otonomy Program Updates , Oxford Finance , Tinnitus Functional Index , American Society , Cell Therapy , Administrative Expenses , Private Securities Litigation Reform Act , Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , அன்னே ராம்சே , டேவிடா வெபர் , இணை லிமிடெட் , அமெரிக்கன் சமூகம் ஆஃப் கீந் செல் சிகிச்சை , வளர்ச்சி செலவுகள் , பரிமாற்றம் தரகு , ஆக்ஸ்ஃபர்ட் நிதி , டின்னிடஸ் செயல்பாட்டு குறியீட்டு ,

Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update

Share:
OTO-313 Phase 2 trial in tinnitus initiated with results expected in mid-2022
OTO-413 Phase 1/2 trial expansion in hearing loss expected to start in second quarter of 2021 with results anticipated in mid-2022
OTO-825 IND-enabling activities underway with preclinical proof-of-concept data to be presented at ASGCT meeting; update on program to be provided in mid-2021
Recent financing extends cash runway into second half of 2023
Conference call and webcast today at 4:30 p.m. ET
SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported financial results for the quarter ended March 31, 2021 and provided an update on its product pipeline and corporate activities. The company will host a conference call and webcast today at 4:30 p.m. ET to discuss recent highlights and financial results. ....

United States , Anne Ramsey , Davida Weber , Roberth Uhl , Co Ltd , American Society Of Gene Cell Therapy , Otonomy Inc , Development Expenses , Exchange Commission , Otonomy Program Updates , Oxford Finance , Tinnitus Functional Index , American Society , Cell Therapy , Administrative Expenses , Private Securities Litigation Reform Act , Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , அன்னே ராம்சே , டேவிடா வெபர் , இணை லிமிடெட் , அமெரிக்கன் சமூகம் ஆஃப் கீந் செல் சிகிச்சை , வளர்ச்சி செலவுகள் , பரிமாற்றம் தரகு , ஆக்ஸ்ஃபர்ட் நிதி , டின்னிடஸ் செயல்பாட்டு குறியீட்டு ,